Story perspectives

Revolutionary Advances in Lung Cancer Treatment Unveiled

10/20/2025

Summary

Story summary

At the 2025 European Society for Medical Oncology Congress, Dr. Natasha Leighl says biomarkers will drive targeted therapies, turning lung cancer into a treatable condition.
mRNA COVID-19 vaccines may boost immune checkpoint inhibitors, doubling survival for vaccinated patients.
Google DeepMind and Yale University reported an AI model identifying MAP4K2 as a target in KRAS-mutant cancers.
Further work is needed to translate these findings into clinical practice.

1 of 1

Story summary

At the 2025 European Society for Medical Oncology Congress, Dr. Natasha Leighl says biomarkers will drive targeted therapies, turning lung cancer into a treatable condition.
mRNA COVID-19 vaccines may boost immune checkpoint inhibitors, doubling survival for vaccinated patients.
Google DeepMind and Yale University reported an AI model identifying MAP4K2 as a target in KRAS-mutant cancers.
Further work is needed to translate these findings into clinical practice.